Lack of follow-up after fecal occult blood testing in older adults: Inappropriate screening or failure to follow up?

Archives of Internal Medicine

Volumn 171, Issue 3, 2011, Pages 249-256

  Carlson, Charlotte M ^a   Kirby, Katharine A ^b   Casadei, Michele A ^b   Partin, Melissa R ^c   Kistler, Christine E ^b   Walter, Louise C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BARIUM ENEMA; COHORT ANALYSIS; COLONOSCOPY; FECAL OCCULT BLOOD TESTING; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SCREENING; SIGMOIDOSCOPY;

AGED; AGED, 80 AND OVER; BARIUM SULFATE; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; CONTRAST MEDIA; ENEMA; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, VETERANS; HUMANS; MALE; MASS SCREENING; MEDICARE; OCCULT BLOOD; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SIGMOIDOSCOPY; TREATMENT REFUSAL; UNITED STATES; VETERANS;

EID: 79951526546     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.372     Document Type: Article

References (38)

1. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348(9040):1467-1471. (Pubitemid 26400241)
2. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040): 1472-1477. (Pubitemid 26400242)
3. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003;95(3):230-236. (Pubitemid 36240636)
4. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149(9):627-637.
5. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59(1):27-41.
6. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750-2756. (Pubitemid 32525372)
7. Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7): 465-473.
8. Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150(12):849-857, W152.
9. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005; 142(2):86-94.
10. Garman KS, Jeffreys A, Coffman C, Fisher DA. Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Am J Med Sci. 2006;332(4):159-163. (Pubitemid 44563800)
11. Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 1999;91(19):1641-1646. (Pubitemid 29479931)
12. Sharma VK, Vasudeva R, Howden CW. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey. Am J Gastroenterol. 2000;95(6):1551-1556. (Pubitemid 30396319)
13. Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006; 15(6):1232-1235.
14. Kussman MJ. VHA Directive 2007-004: colorectal cancer screening. http://www1.va.gov/vhapublications/ViewPublication.asp?pub-ID=1530. Accessed December 5, 2009.
15. Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L. Screening for colorectal neoplasia: physician's adherence to complete diagnostic evaluation. Am J Public Health. 1993;83(11):1620-1622. (Pubitemid 23320051)
16. Baig N, Myers RE, Turner BJ, et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol. 2003;98(9):2078-2081. (Pubitemid 37185809)
17. Jimbo M, Myers RE, Meyer B, et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med. 2009;7(1):11-16.
18. Rao SK, Schilling TF, Sequist TD. Challenges in the management of positive fecal occult blood tests. J Gen Intern Med. 2009;24(3):356-360.
19. Singh H, Kadiyala H, Bhagwath G, et al. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol. 2009;104(4):942-952.
20. Etzioni DA, Yano EM, Rubenstein LV, et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum. 2006;49 (7):1002-1010. (Pubitemid 44060854)
21. Hynes DM, Koelling K, Stroupe K, et al. Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care. 2007;45(3):214-223.
22. United States Department of Veterans Affairs. VA Information Resource Center data sources by name. http://www.virec.research.va.gov/DataSourcesName/ DataNames.htm. Accessed December 5, 2009.
23. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
24. Charlson ME, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-1251. (Pubitemid 24361532)
25. US Census Bureau. Census 2000 summary file 3 - United States/prepared by the US Census Bureau, 2002. http://www2.census.gov/census-2000/datasets/Summary- File-3/0-National/. Accessed December 5, 2009.
26. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706. (Pubitemid 29126745)
27. Sohn MW, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006;4:2.
28. Turner B, Myers RE, Hyslop T, et al. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med. 2003;18(5):357-363. (Pubitemid 36751077)
29. Shields HM, Weiner MS, Henry DR, et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Am J Gastroenterol. 2001;96(1):196-203. (Pubitemid 32104828)
30. Canada RE, Turner B. Talking to patients about screening colonoscopy: where conversations fall short. J Fam Pract. 2007;56(8):E1-E9.
31. Wolf MS, Baker DW, Makoul G. Physician-patient communication about colorectal cancer screening. J Gen Intern Med. 2007;22(11):1493-1499. (Pubitemid 47568676)
32. Fisher DA, Galanko J, Dudley TK, Shaheen NJ. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol. 2007;5(8):991-996. (Pubitemid 47127025)
33. Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract. 2001;4(4):150-156.
34. Larson MF, Ko CW, Dominitz JA. Effectiveness of a provider reminder on fecal occult blood test follow-up. Dig Dis Sci. 2009;54(9):1991-1996.
35. Bastani R, Yabroff KR, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer. 2004;101(5)(suppl): 1188-1200. (Pubitemid 39100413)
36. Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA. 2004;291(20):2466-2470. (Pubitemid 38669190)
37. Powell AA, Gravely AA, Ordin DL, Schlosser JE, Partin MR. Timely follow-up of positive fecal occult blood tests strategies associated with improvement. Am J Prev Med. 2009;37(2):87-93.
38. Montaño DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85(6):795-800.